Asgin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asgin

Quick Facts about Asgin

Property Description
Active Ingredient Tinidazole
Form Film-coated tablet (Oral)
Pharmacological Class Nitroimidazole Antimicrobial
General Purpose To eliminate susceptible anaerobic bacteria and protozoa
Origin Synthetic

What Type of Medicine is Asgin and Its Active Ingredient, Tinidazole?

Asgin is a pharmaceutical preparation that acts as a synthetic anti-infective agent, whose active component is the drug Tinidazole. Tinidazole is officially classified as a Nitroimidazole Antimicrobial agent, a category of medicine developed to target and eliminate certain parasitic and bacterial pathogens. This classification confirms its defined role in managing infections caused by susceptible organisms. The drug is focused on providing highly effective antimicrobial activity against organisms that thrive in low-oxygen environments, such as specific protozoa and anaerobic bacteria. The efficacy of this drug class makes it an essential prescription-only medication for targeted treatment.

Composition, Origin, and Therapeutic Purpose

The functional identity of Asgin is derived entirely from its single active ingredient, Tinidazole, which is a synthetic 5-nitroimidazole derivative. The compound is chemically manufactured to achieve its specific biological action, ensuring its differentiation from the first-generation nitroimidazoles through structural modifications. Asgin is intended for the oral route of administration and is most commonly supplied as a film-coated tablet. The primary therapeutic goal of the medicine is the resolution of infectious disease by destroying the responsible microorganisms. As a second-generation nitroimidazole, Tinidazole exhibits potent antiprotozoal and bactericidal effects against target pathogens. This specialized activity ensures the targeted action needed to resolve the underlying infectious process, providing a key benefit for patients facing certain parasitic or anaerobic bacterial conditions.

Regulatory References

  1. Tinidazole: DailyMed Labeling

What side effects are possible with Asgin?

Possible Side Effects and Safety Information

The official safety profile for Asgin (Tinidazole) classifies documented adverse reactions by frequency and the body system affected, focusing primarily on the gastrointestinal and nervous systems. This nitroimidazole antimicrobial medicine has documented frequency categories for various effects, ranging from common to rare.


Adverse Reaction Scope and Classification

Adverse reactions that are officially classified as Common include metallic taste, nausea, vomiting, abdominal pain, diarrhea, headache, and dizziness. Reactions categorized as Uncommon or Rare/Not Known typically involve the skin (e.g., rash, pruritus), blood/lymphatic system (transient leukopenia), and instances of hypersensitivity.

Serious Adverse Reactions and Safety Constraints

Regulatory documents list certain adverse reactions as serious, including convulsions (seizures), ataxia, and the potential for peripheral neuropathy (numbness/paresthesia). This neurological risk is specifically associated with prolonged administration or repeated courses of therapy. Severe hypersensitivity reactions, such as angioedema, are also documented.

Specific safety restrictions are defined in the official labeling. The drug is contraindicated in patients with active organic central nervous system (CNS) disease and in combination with alcohol (ethanol), which can lead to a severe disulfiram-like reaction. Furthermore, use is generally contraindicated during the first trimester of pregnancy, and caution is specified for patients with severe hepatic impairment due to the risk of drug accumulation. These constraints define the boundaries of the medicine's safe use as established by regulatory authorities.

Overdose and Emergency Response

Overdose and When to Seek Help

Aspirin (Salicylate) overdose is a medical emergency that requires immediate professional attention. This section describes the official regulatory information regarding recognition and necessary emergency actions for overdose, strictly derived from authoritative government sources.

Documented Overdose Manifestations

Official regulatory information describes a range of overdose signs. Early or mild symptoms often include ringing in the ears (tinnitus), vomiting, dizziness, and hyperventilation. In severe or life-threatening toxicity, these symptoms can progress rapidly to central nervous system effects such as confusion, seizures, or coma, as well as critical metabolic disturbances like severe metabolic acidosis and hyperthermia (high fever). Respiratory distress and pulmonary edema are also documented severe outcomes.

Required Emergency Actions

Immediate action is mandatory for any known or suspected overdose, even if the person appears asymptomatic.

Action Condition
Call Emergency Services If the person is unconscious, having seizures, or experiencing trouble breathing.
Contact Poison Control Immediately for advice following any potential overdose ingestion.

Treatment in a medical facility focuses on supportive care, monitoring serum salicylate levels, correcting life-threatening acid-base imbalances, and employing procedures like activated charcoal or urinary alkalinization to eliminate the drug from the body. Chronic toxicity, which can occur from slightly excessive dosing over time, is often more serious in older adults and may present with non-specific symptoms like confusion or fever. The treatment of salicylate poisoning does not involve a specific antidote.

Therapeutic Uses of Asgin

The primary therapeutic role of Asgin (Tinidazole) is in managing infectious diseases caused by susceptible protozoa and specific anaerobic bacteria. It is generally applied across domains where additional symptomatic support is needed.

The medicine is commonly used to help with conditions presenting with acute episodes, including the parasitic diseases Trichomoniasis, Giardiasis, and various forms of Amebiasis (intestinal and Amebic Liver Abscess), and for managing bacterial infections such as Bacterial Vaginosis. This application is relevant when symptom clusters may become intense or disruptive, specifically patterns of infectious gastrointestinal distress and urogenital symptoms like abnormal discharge, itching, and inflammation. The general benefit supports the patient during difficult episodes by easing distress and may assist with maintaining functional stability in situations where symptoms interfere with routine activities. This medicine is applied to provide support that helps ease the overall symptom burden of uncomfortable local manifestations.

Quick Fact: Relief for Key Symptoms
Symptom Domain Associated Conditions
Gastrointestinal Distress Giardiasis, Intestinal Amebiasis
Urogenital Manifestations Trichomoniasis, Bacterial Vaginosis
Systemic Signs (Fever/Pain) Amebic Liver Abscess

Regulatory References

  1. NIH DailyMed Drug Information

Eligibility and Restrictions for Use

The official eligibility profile for Asgin (Tinidazole) is defined by stringent regulatory classifications outlining who is permitted to use the medicine and who is strictly prohibited.

Populations for Whom Use is Contraindicated

Asgin must not be used by patients with a known hypersensitivity to tinidazole or any other 5-nitroimidazole derivatives (such as metronidazole). Use is also formally contraindicated in patients with a history of blood dyscrasias or organic neurological disorders, and in patients with Cockayne Syndrome.

Age and Reproductive Status

Use is contraindicated during the first trimester of pregnancy and in nursing mothers. Women should not breastfeed during treatment and for at least 72 hours following the last dose. For the pediatric population, safety and effectiveness have not been established in children three years of age and younger. In children over three, the drug is approved only for Giardiasis and Amebiasis; use is not established for other labeled indications.

Conditional Use and Restrictions

Administration requires caution in patients with impaired hepatic function and in those with a history of seizures or peripheral neuropathy. Dosage adjustments are generally not necessary for renal impairment, but special consideration is required for patients undergoing hemodialysis.

What should I know about interactions with other medicines?

Asgin (Tinidazole) has documented interaction patterns defined by regulatory authorities that involve both pharmacokinetic changes and pharmacodynamic constraints with various substances.

Prohibited Combinations and Timing Rules

A mandatory restriction is the contraindication of co-administration with Disulfiram. Tinidazole must not be administered until at least two weeks (14 days) have passed since the last Disulfiram dose. A significant pharmacodynamic interaction occurs with Alcohol and Ethanol-containing products. Concurrent use induces a severe disulfiram-like reaction, necessitating that all forms of alcohol be strictly avoided during treatment and for a period of at least 72 hours following the final dose of Tinidazole.

Metabolic and Exposure Alterations

Tinidazole is subject to biotransformation primarily by the CYP3A4 enzyme system. Co-administration with strong CYP3A4 inducers (such as Rifampin) can reduce Tinidazole's plasma concentrations and exposure. Conversely, CYP3A4 inhibitors (such as Cimetidine or Ketoconazole) may increase the drug's plasma levels.

Tinidazole may also enhance the effects of Oral Coumarin Anticoagulants, resulting in a prolonged prothrombin time. It may further increase the plasma concentrations of certain co-administered drugs, including Lithium, Fluorouracil, Cyclosporine, and Tacrolimus. Lastly, the official label notes that patients with severe hepatic impairment may experience drug accumulation, potentially increasing the risk of concentration-dependent interactions. The overall interaction structure is defined by absolute timing requirements and pharmacokinetic modulation of drug clearance.

Mechanism of Action

Selective Activation by Anaerobic Enzymes

The mechanism of Tinidazole is initiated by its selective prodrug activation, which relies entirely on the unique low redox potential enzymes (like ferredoxin) found in susceptible anaerobic pathogens. This process converts the inert Tinidazole molecule into a highly reactive, toxic form exclusively within the microbe. This chemical conversion is the prerequisite molecular step that determines the drug's biological effect.


Destruction of Pathogen Genetic Material

The newly formed cytotoxic nitro-radicals act on the microbe's genetic material, leading to DNA damage. These radicals covalently bind to the microbial DNA, causing strand breaks and inhibiting essential DNA synthesis and repair. This irreversible molecular event culminates in the physical destruction of the pathogen through a bactericidal/antiprotozoal action, which contributes to the drug's overall pharmacological effect profile.


Mechanistic Constraints and Target Specificity

The entire mechanism is fundamentally constrained by its dependence on anaerobic physiology, meaning the drug is functionally inactive against aerobic bacteria and human cells, which lack the requisite activating enzymes. This mechanistic limitation precisely defines the drug's highly specific target profile, as the activating pathway is absent in aerobic biological systems.

Dosage and Administration Information

Asgin is an anti-infective agent administered exclusively by the oral route as a film-coated tablet, available in strengths such as 500 mg and 1 g (1000 mg). The general principle of its use is defined by specific, short-term, indication-based protocols. The medicine is consistently recommended to be taken with food to ensure proper administration and reduce potential gastrointestinal upset.

Dosing typically follows a single-day or short-course once daily schedule. For protozoal infections like Trichomoniasis and Giardiasis, the labeled regimen specifies a single 2 g dose. Multi-day courses include 2 g once daily for three days for Intestinal Amebiasis, and 2 g once daily for three to five days for Amebic Liver Abscess. For Bacterial Vaginosis, two distinct short-course regimens are available: 2 g once daily for 2 days, or 1 g once daily for 5 days.

Administration protocols include two key restrictions tied to proper use. For patients diagnosed with Trichomoniasis, guidelines specify the simultaneous treatment of sexual partner(s) with the same single 2 g dose. Furthermore, all alcoholic beverages and preparations containing ethanol or propylene glycol must be avoided during the course of therapy and for 3 days following the final dose. For pediatric patients (aged three years and older), the dose for Giardiasis and Amebiasis is 50 mg/kg body weight per dose, up to a maximum of 2 g.

Recent Clinical Evidence

Research Evidence Overview


Evidence for Use in Trichomoniasis and Giardiasis

Research examining Asgin for the infections Trichomoniasis and Giardiasis primarily relies on Randomized Controlled Trials (RCTs) and systematic reviews. For both conditions, studies assessed microbiological cure (confirmed absence of the causative organism) and monitored the patterns of change in associated symptoms. Trials described patterns of short-term microbiological clearance in the populations studied. For Giardiasis, evidence includes data from pediatric patients ge 3 years of age, and reports described that single-day regimens achieved parasite clearance measurements consistent with alternative standard treatments. A limitation across both fields is that long-term effects and the durability of the response are not fully established, as follow-up durations were often limited to the short-term clearance phase.


Evidence for Use in Amebiasis

Research was conducted on Asgin for Intestinal Amebiasis and Amebic Liver Abscess. The evidence base is derived from multi-center trials and older comparative studies. For intestinal infection, research monitored parasite clearance. For amebic liver abscess, follow-up tracked clinical resolution and the reduction of lesion size over several months. A limitation noted in the research is that many of the original studies supporting this indication are modest in sample size or were conducted without direct comparison to all current therapeutic options, meaning comparative evidence is lacking in some areas.


Evidence Gaps and Special Populations

Research for Bacterial Vaginosis monitored recurrence rates, highlighting that initial microbiological success does not equate to long-term freedom from the condition. For all indications, data for certain groups, such as pregnant or lactating women, remain insufficient, and the results primarily apply to the populations studied in the original clinical evaluations.

Key Studies & References

  1. Tinidazole Found to Be Better Than Metronidazole for Giardiasis: Systematic Review and Network Meta-analysis (2017)

Frequently Asked Questions (FAQ)

Common questions about Asgin (FAQ)


Q: Is Asgin the same kind of medicine as aspirin or ibuprofen?

Asgin (Tinidazole) is not the same kind of medicine as aspirin or ibuprofen. Official classification defines Asgin as a Nitroimidazole Antimicrobial agent, which means it is used specifically to eliminate certain protozoa and anaerobic bacteria.

Aspirin and ibuprofen, in contrast, belong to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class and primarily work to reduce pain, fever, and inflammation.


Q: What should I avoid eating or drinking while taking Asgin?

Official instructions state that all alcoholic beverages and products containing ethanol or propylene glycol must be strictly avoided while taking Asgin. This restriction is necessary because combining them can cause a severe reaction and must continue for at least 72 hours after the final dose.

The medicine is also recommended to be taken with food to help reduce the possibility of stomach upset.


Q: Does Asgin interact with blood pressure medications?

Regulatory information indicates that Asgin is metabolized by a specific liver enzyme system called CYP3A4. If a blood pressure medication is classified as a strong inducer (speeds up metabolism) or inhibitor (slows metabolism) of this enzyme, it could potentially change the concentration of Asgin in the blood. This specific interaction information would be found in the official product labeling.


Q: Can I take Asgin if I have asthma or breathing difficulties?

Asgin is formally contraindicated, or prohibited, in individuals who have a known hypersensitivity (allergy) to the drug or any similar medicines. Severe allergic reactions can sometimes involve difficulty breathing. While the regulatory label does not specifically mention asthma, it is important to review this information as part of your overall eligibility.


Q: Why is the protective coating on some Asgin pills important?

Asgin is supplied as a film-coated tablet. Film-coating is a common manufacturing technique in pharmacy. Coatings serve multiple purposes, such as protecting the tablet from moisture, masking a potentially unpleasant taste, or controlling where the tablet dissolves in the digestive tract.


Q: What is the consensus in the medical community about Asgin's benefits versus risks?

The medical understanding of this medicine is reflected in the official regulatory documents. These documents list both the drug's established benefits (its approved uses for specific infections) and its documented risks (warnings, contraindications, and adverse reactions) based on clinical data. The goal of regulatory review is to ensure that the benefits generally outweigh the risks for the intended patient population.


Q: How long does Asgin stay in your system after you stop taking it?

According to the official pharmacokinetic data, the active ingredient in Asgin, Tinidazole, has an elimination half-life of approximately 12 to 14 hours in healthy adults. This figure indicates the time it takes for the body to clear half of the drug from the bloodstream. The official labeling provides this elimination half-life for informational purposes.


Q: Can taking Asgin long-term cause any liver or kidney problems?

The regulatory documents state that caution is necessary for patients with severe liver impairment, as this can lead to the drug accumulating in the body. Long-term use or repeated courses are generally not recommended due to the potential for neurological risks, such as peripheral neuropathy (nerve damage), which are noted in the safety information. Asgin is intended for short-course treatment protocols.


Q: Is it normal to feel a ringing in the ears (tinnitus) when taking Asgin?

Official adverse reaction reports list side effects such as headache and dizziness. While a ringing in the ears (tinnitus) is not commonly listed, the labeling does note that vertigo, which is a sensation of spinning, has been reported. This suggests the potential for effects on the nervous system, which should be monitored.


Q: Is there a generic version of Asgin available?

Yes, the active ingredient in Asgin, Tinidazole, is available in the United States and other markets under various brand names as well as lower-cost generic versions. Generic versions are reviewed by regulatory agencies to ensure they meet the same high standards of quality and effectiveness as the original branded product.


Q: What is the shelf life of Asgin tablets?

Regulatory storage guidelines require that Asgin tablets must not be used beyond the expiration date printed on the packaging. To maintain their stability and effectiveness, they must be kept in the original container, tightly closed, and protected from moisture, at the recommended temperature.


Q: Are there any specific lifestyle changes recommended when starting Asgin?

The most critical instruction is the strict avoidance of all forms of alcohol, which is a mandatory restriction due to the risk of a severe disulfiram-like reaction. This must be followed for at least 72 hours after treatment ends. Apart from this mandatory restriction, general lifestyle changes are not typically specified in the regulatory labeling.


Q: How does Asgin's mechanism of action compare to Tylenol?

Asgin (Tinidazole) and Acetaminophen (Tylenol) work in completely different ways. Asgin is an Antimicrobial that works by damaging the DNA of susceptible pathogens in the body. Acetaminophen works primarily in the central nervous system to relieve pain and reduce fever; it has no antimicrobial activity and belongs to an entirely different drug class.


Q: Does Asgin have any effect on sleep or cause drowsiness?

The drug’s official labeling lists dizziness and headache as common adverse reactions. While direct drowsiness is not specifically listed as a common effect, official information cautions that the drug may affect alertness or coordination, which is a consideration for daily activities.


Q: Can I use Asgin for muscle soreness after exercise?

No. The regulatory documents define Asgin's approved uses, or indications, as treatment for specific protozoal and anaerobic bacterial infections (such as giardiasis or bacterial vaginosis). It is not indicated or studied for the treatment of general conditions like muscle soreness after exercise.


Q: Does taking Asgin make me dizzy or lightheaded?

Yes, dizziness is listed in the official safety profile as a common adverse reaction reported by patients. The regulatory information also notes that vertigo, a feeling of spinning, has been reported. These are recognized effects on the nervous system.


Q: What are the risks of suddenly stopping Asgin if I've been taking it for a long time?

Asgin is intended for short-course treatment only. The primary risk of stopping an antimicrobial before the prescribed course is that the infection may not be fully eliminated, potentially leading to treatment failure. Long-term or repeated use is cautioned against in regulatory documents due to the risk of neurological damage.


Q: Is it okay to take Asgin on an empty stomach?

It is officially recommended that Asgin be taken with food, either during or immediately after a meal. This instruction is provided to help reduce the potential for experiencing gastrointestinal upset, such as nausea or stomach pain, which are noted side effects.


Q: When should I avoid taking Asgin before bedtime?

Asgin is typically prescribed for a once-daily schedule. Due to the potential for side effects like headache or dizziness, patients are generally advised to discuss the optimal timing of their once-daily dose with their healthcare provider.


Q: Does Asgin interact with common cold or flu medicines?

The most important interaction rule applies to alcohol and propylene glycol. Patients should confirm that any cold or flu preparation they take—whether liquid, capsule, or tablet—does not contain these ingredients, as they can trigger a severe reaction when combined with Asgin.

How should Asgin be stored and disposed of?

Storage Requirements

Asgin (Tinidazole) tablets must be stored under specific regulatory conditions to maintain stability and effectiveness.

Storage Component Official Requirement
Temperature Store at 25 C (77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F).
Container & Protection Keep in the original, tightly closed container and protect from moisture.
Stability Do not use the tablets beyond the printed expiration date.
Child Safety Mandatory to keep the medication out of the reach of children.

Disposal Instructions

Unused or expired Asgin must be disposed of in accordance with official guidelines. The product must not be flushed down the toilet or poured into a drain. Disposal should utilize a medicine take-back program or adhere strictly to applicable state and local regulations for proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Asgin found in:

A-Z Index: